Abo Ramadan, Usama

Escutenaire, Sophie

Halavaara, Juha Tapio

Hemminki, Akseli Eetu

Kanerva, Anna

Lavilla Alonso, Sergio

Pesonen, Sari

Saksela, Kalle

Tatlisumak, Turgut

PLoS ONE

PubMed

Development of new cancer treatments focuses increasingly on the relation of cancer tissue with its microenvironment. A major obstacle for the development of new anti-cancer therapies has been the lack of relevant animal models that would reproduce all the events involved in disease progression from the early-stage primary tumor until the development of mature metastatic tissue. To this end, we have developed a readily imageable mouse model of colorectal cancer featuring highly reproducible formation of spontaneous liver metastases derived from intrasplenic primary tumors. We optimized several experimental variables, and found that the correct choice of cell line and the genetic background, as well as the age of the recipient mice, were critical for establishing a useful model system. Among a panel of colorectal cancer cell lines tested, the epithelial carcinoma HT29 line was found to be the most suitable in terms of producing homogeneous tumor growth and metastases. In our hands, SCID mice at the age of 125 days or older were the most suitable in supporting consistent HT29 tumor growth after splenic implantation followed by reproducible metastasis to the liver. A magnetic resonance imaging (MRI) protocol was optimized for use with this mouse model, and demonstrated to be a powerful method for analyzing the antitumor effects of an experimental therapy. Specifically, we used this system to with success to verify by MRI monitoring the efficacy of an intrasplenically administered oncolytic adenovirus therapy in reducing visceral tumor load and development of liver metastases. In summary, we have developed a highly optimized mouse model for liver metastasis of colorectal cancer, which allows detection of the tumor load at the whole body level and enables an accurate timing of therapeutic interventions to target different stages of cancer progression and metastatic development

Sergio Lavilla-Alonso

Usama Abo-Ramadan

Juha Halavaara

Sophie Escutenaire

Turgut Tatlisumak

Kalle Saksela

Anna Kanerva

Akseli Hemminki

Sari Pesonen

Directory of Open Access Journals

Optimized mouse model for the imaging of tumor metastasis upon experimental therapy.

Helsingin yliopiston digitaalinen arkisto

Optimized Mouse Model for the Imaging of Tumor Metastasis upon Experimental Therapy

Crossref

Abnormal lymphoid organ development in immunodeficient mutant mice.

Active versus passive mechanisms in metastasis: Do cancer cells crawl into vessels, or are they pushed?

Determination of clonality of metastasis by cell-specific color-coded fluorescent-protein imaging.

Environment-mediated drug resistance: A major contributor to minimal residual disease.

Impact of stroma on the growth, microcirculation, and metabolism of experimental prostate tumors.

In vivo colorcoded imaging of the interaction of colon cancer cells and splenocytes in the formation of liver metastases.

Local administration of il-12-transfected dendritic cells induces antitumor immune responses to colon adenocarcinoma in the liver in mice.

Metastasis: From dissemination to organ-specific colonization.

Metastatic dormancy imposed by the primary tumor: Does it exist in humans?

Microenvironmental regulation of metastasis.

Modeling metastasis in vivo.

Orthotopic microinjection of human colon cancer cells in nude mice induces tumor foci in all clinically relevant metastatic sites.

Parallel progression of primary tumours and metastases.

Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles.

Role of diffusionweighted magnetic resonance imaging in the differential diagnosis of focal hepatic lesions.

Spontaneous and genetically engineered animal models; use in preclinical cancer drug development.

Suppression of colorectal cancer liver metastasis and extension of survival by expression of apolipoprotein(a) kringles.

Surgical treatment of hepatic colorectal metastasis: Evolving role in the setting of improving systemic therapies and ablative treatments in the 21st century.

Targeting gene-virotherapy of cancer.

The management of colorectal liver metastases: Expanding the role of hepatic resection in the age of multimodal therapy.

Treatment of ovarian cancer with a tropism modified oncolytic adenovirus.

Tumor cell dissemination in a human colon cancer animal model: Orthotopic implantation or intraportal injection?

Tumor microvasculature and microenvironment: Targets for anti-angiogenesis and normalization.

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3207818

Optimized Mouse Model for the Imaging of Tumor Metastasis upon Experimental Therapy

Abstract

Similar works

Full text

Available Versions

Directory of Open Access Journals

Helsingin yliopiston digitaalinen arkisto

Crossref